CRISPR-U™ Gene Knockout Cell Line
Strategy
PATL1 Gene Knockout Strategy
CRISPR-U™ technology (CRISPR based), developed by Ubigene, is more efficient than general
CRISPR/Cas9 technology in double-strand breaking and homologous recombination. With CRISPR-U™, Ubigene has
successfully edited over 3000 genes on more than 100 types of cell lines.
Objective
To create a Human PATL1 Knockout
model in cell line by
CRISPR-U™-mediated
genome
engineering.
Target gene info 
| Official symbol | PATL1 |
| Gene id | 219988 |
| Organism | Homo sapiens |
| Official full symbol | PAT1 homolog 1, processing body mRNA decay factor |
| Gene type | protein-coding |
| Also known as | Pat1b, hPat1b |
| Genomic regions | Chromosome 11 |
Strategy Summary
This gene has 1 protein coding transcripts：
| Name | Transcript ID | bp | Protein | Biotype | CCDS | UniProt Match | RefSeq Match | Flags |
| PATL1-201 | ENST00000300146.10 | 4129 | 770aa | Protein coding | CCDS44613 | Q86TB9-1 | NM_152716.3 | TSL:1, GENCODE basic, APPRIS P1, MANE Select v0.92, |
| PATL1-202 | ENST00000531919.1 | 440 | No protein | Retained intron | - | - | - | TSL:5, |
Strategy
Click to get
Red Cotton™ Assessment
Project Difficulty Level unknown
| Target Gene | PATL1 |
| This KO Strategy | loading |
| Red Cotton™ Notes | Gene PATL1 had been KO in hela cell line. |
Aforementioned information comes from Ubigene database. Different origin of cell lines may have
different condition. Ubigene reserved all the right for final explanation.
Special deals for this gene:
$49
Single gRNA plasmid off-shelf
$599
Single gRNA lentivirus
Work flow
Comment: